baber/WOPTO huggingface dataset:
Patent MY-193931-A (MY)
Title: Determination of tuberculation in a fluid distribution system
Inventor: YUSUF SHABBIR
IPC: G01N29/44
Filed: 2016-06-10
Abstract: Examples of determining tuberculation in a fluid distribution system (110) are disclosed. In one example implementation according to aspects of the present disclosure, an acoustical wave generator (130) generates an acoustical wave within a fluid path (112) of a fluid distribution system (130). A first acoustical sensor (132) and a second acoustical sensor (134) sense the acoustical wave. An acoustical signal analysis module (124) determines an amount of tuberculation within the fluid distribution system (110) by analyzing the sensed acoustical wave.
Patent MY-197672-A (MY)
Title: Room temperature stable lyophilized protein
Inventor: TANG XIAOLIN
IPC: A61K9/00
Filed: 2017-10-06
Abstract: Stable lyophilized therapeutic protein compositions and their methods of manufacture are provided. Specifically, the use of water as a solid cake plasticizer and protein stabilizer is described. Also, the inclusion of a multicomponent stabilizer comprising a larger molecular entity and a smaller molecular entity is described. Also, the inclusion of post-drying annealing under certain conditions improves protein stability. Proteins are predicted to remain stable over 24 months at 25?C. (FIG. 2)
Patent MY-195996-A (MY)
Title: Process of Improving Water Solubility of Sesamin
Inventor: KONGTAWELERT PRACHYA
IPC: A23D9/007
Filed: 2017-02-14
Abstract: A process of improving water solubility of sesamin by creating a mixture of poloxamer and surfactant in appropriate proportion and sequence wherein the sesamin complex compounds derived from the process are at a nanometer (nm) scale and are highly soluble in water. Upon adding a maltodextrin into the mixture at a preferable speed and drying or freez-drying said mixture thereafter, the resulting sesamin powders are highly stable and can actively release its medicinal effect for a long period of time.
Patent MY-196248-A (MY)
Title: Method and Electronic Device for Controlling Display
Inventor: LEE JONG-MOO
IPC: G06F3/041
Filed: 2018-01-30
Abstract: An electronic device (101) for processing a touch input is provided. The electronic device (101) includes a touch screen display (702, 703) having a first aspect ratio; a memory (130) that stores at least one application; and a processor (840) electrically connected to the touch screen display (702, 703) and the memory (130), wherein the processor (840) is configured to compare a second aspect ratio of a user interface of one of the at least one application with the first aspect ratio, display the user interface in a first area having the second aspect ratio of the touch screen display (702, 703) when the second aspect ratio is smaller than the first aspect ratio, display at least one function button, which is not a part of the application, in a second area of the touch screen display (702, 703) that does not overlap the first area, display the user interface in an entire area of the touch screen display (702, 703) when the second aspect ratio is equal to the first aspect ratio, and display the at least one function button on the touch screen display (702, 703) such that the function button overlaps the user interface. (Fig. 4B)
Patent MY-197326-A (MY)
Title: Penetrating compositions with reduced cloud point for acidizing applications
Inventor: GEORGE SHOY CHITTATTUKARA
IPC: C09K8/60
Filed: 2019-08-06
Abstract: Described herein are penetrating compositions that include ethoxylated C12- C16 alcohols, 2-ethyl hexanol, and isopropyl alcohol, and are injectable into a near-wellbore subterranean formation. The penetrating compositions may include water or brine. The penetrating compositions are free of ethylene glycol monobutyl ether (EGMBE) and nonylphenol ethoxylates (NPE). Also described are methods of using penetrating compositions that that include introducing a penetrating composition into a near-wellbore formation and reducing surface tension at an oil/water interface within the formation.
Patent MY-159898-A (MY)
Title: Breeding cage for experimental animal
Inventor: LIN JUNG YU
IPC: A01K1/03
Filed: 2011-09-09
Abstract: A BREEDING CAGE (1) FOR EXPERIMENTAL ANIMALS IS COMPOSED OF A BOX BODY (2) AND A COVER BODY (3) COVERED WITH THE BOX BODY. A SIDE OF THE COVER BODY IS DISPOSED WITH AN AIR INTAKE VALVE (7) AND AN AIR VENT VALVE (8). A PARTITION (6) IS DISPOSED IN THE COVER BODY TO ALLOW AN INSIDE OF THE COVER BODY TO DEFINE A DRAINAGE CHANNEL (33). FRESH AIR ENTERS FROM THE AIR INTAKE VALVE AND IS THEN DOWNWARDLY INTRODUCED INTO THE BOX BODY THROUGH THE DRAINAGE CHANNEL AND PUSHES AIR ORIGINALLY WITHIN THE BOX BODY TO EXHAUST IT AWAY FROM THE AIR VENT VALVE TO ALLOW AIR WITHIN THE BOX BODY TO PERFORM CIRCULATION.
Patent MY-190179-A (MY)
Title: Method of growing semipolar gallium nitride film
Inventor: Azzuliani Supangat
IPC: H01L21/285
Filed: 2017-12-21
Abstract: A method of growing semipolar GaN on m-plane sapphire substrate using metalorganic chemical vapor deposition (MOCVD) is described. A suitable m-plane Al2O3 (1- 100) is used as substrate. Nitridation of substrate is performed at growth temperature with gaseous H2 and NH3 flow. After a desired time has elapsed, growth of planar m-plane GaN layer on the substrate is performed with gaseous (Ga(CH3)3), H2 and NH3 flow. Semipolar m- plane GaN (11-22) is grown on the substrate. The surface morphology of semipolar (11-22) GaN has improved as captured by atomic force microscope and scanning electron microscope.
Patent MY-193358-A (MY)
Title: Pull-out shading and rainproof top cover
Inventor: QU WEI
IPC: E04B7/16
Filed: 2018-05-23
Abstract: The utility model relates to the technical field of prefabricated cubical substations and medium-voltage switchgear devices, in particular to a pull-out shading and rainproof top cover. The pull-out shading and rainproof top cover provided in the present utility model comprises a lower top cover (2), an upper top cover (1), and stop members, wherein, the upper top cover (1) is mounted on the lower top cover (2) and can slide on a top surface of the lower top cover (2), and the stop members are configured to prevent the upper top cover (1) from disengaging from the lower top cover (2). Thus, when the prefabricated cubical substation or medium-voltage switchgear device is to be checked or operated in a rainy day or strong light environment, the upper top cover (1) may be pulled out for shielding against rain or shading, so that the functions of the prefabricated cubical substation or medium-voltage switchgear device can be checked or operated; the stop members can prevent the upper top cover (1) from disengaging from the lower top cover (2) or falling off. In addition, in a state that the upper top cover (1) is not pulled out, the upper top cover (1) and the lower top cover (2) form a double-layer top cover structure, with air circulating between them. Thus, the heat dissipation capability of the prefabricated cubical substation or medium-voltage switchgear device under direct sunlight is improved.
Patent SG-10201803427Y-A (SG)
Title: Coating for a nickel-base superalloy
Inventor: NDAMKA NGUNJOH L
Filed: 2018-04-24
Abstract: Coating for a Nickel-base Superalloy An arrangement comprising a component (203) adjacent to a ceramic matrix composite in a gas turbine engine is shown. The component comprises a nickel-base superalloy substrate (301) and a cobalt-modified beta-nickel- 5 aluminide coating (302) on the substrate to prevent interdiffusion between the substrate and the ceramic matrix composite. The substrate is coated by depositing a cobalt layer on the substrate, depositing an aluminium layer on the cobalt layer and then forming a cobalt-modified beta nickel aluminide coating. Figure 3 10
Patent SG-10201803472Q-A (SG)
Title: Substituted chromanes and method of use
Inventor: KYM PHILIP
Filed: 2015-10-28
Abstract: SUBSTITUTED CHROMANES AND METHOD OF USE The invention provides for compounds of formula (I), wherein R1, X, Y, R4, R5, R6, R7, R8, R9, R10, R11, R12, R13, R14, m, and R" have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions mediated and modulated by CFTR, including cystic fibrosis, Sjögren's syndrome, pancreatic insufficiency, chronic obstructive lung disease, and chronic obstructive airway disease. Also provided are pharmaceutical compositions comprised of one or more compounds of formula (I). [Formula (I)]
Patent SG-10201808663Y-A (SG)
Title: Resin molded product manufacturing apparatus, resin molding system, and resin molded product manufacturing method
Inventor: HIDEO ICHIHASHI
Filed: 2018-10-02
Abstract: RESIN MOLDED PRODUCT MANUFACTURING APPARATUS, RESIN MOLDING SYSTEM, AND RESIN MOLDED PRODUCT MANUFACTURING METHOD OF THE DISCLOSURE 5 There is provided a resin molded product manufacturing apparatus, resin molding system, and resin molded product manufacturing method that can reduce variation in thickness of a resin molded product. The resin molded product manufacturing apparatus includes a first platen, a first mold chase holder provided on the first platen, and a second platen disposed so as to face the first platen. The first 10 mold chase holder includes a first heat insulating member on a side closer to the first platen, and a first mold chase holder heater on a side closer to the second platen. The first platen includes a first platen heater configured to heat the first platen. FIG. 1 15
Patent SG-11201407003X-A (SG)
Title: A narrow space rescue training device
Inventor: HOCK PHENG TAN
IPC: G09B9/00
Filed: 2012-10-31
Abstract: (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 31 October 2013 (31.10.2013) WIPOIPCT (10) International Publication Number WO 2013/162465 A1 (51) International Patent Classification: E04B 1/19 (2006.01) G09B 9/00 (2006.01) (21) International Application Number: (22) International Filing Date: (25) Filing Language: (26) Publication Language: PCT/SG2012/000410 31 October 2012 (31.10.2012) English English (30) Priority Data: 201210130335.6 28 April 2012 (28.04.2012) CN (72) Inventor; and (71) Applicant HOCK : PHENG, Tan [SG/SG]; 8 Boon Lay Way, #10-10 Trade Hub 21, Singapore 609964 (SG). (74) Agent: ALPHA & OMEGA LAW CORPORATION; 24 Peck Seah Street, #02-12 Nehsons Building, Singapore 079314 (SG). (81) Designated States (unless otherwise indicated, for every kind of national protection available)'. AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available)'. ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG). Published: — with international search report (Art. 21(3)) (54) Title: A NARROW SPACE RESCUE TRAINING DEVICE •t CJ (57) Abstract: The present invention provides a nar­ row space rescue training device (1) in the form of a three dimensional grid framework. This three dimen­ sional grid framework is constructed in layers (10, 20, 30.. 60) using multidirectional connectors (11, 13, 15.... 33, 35) to plug connect horizontal frame pipes (14, 14, 16....36, 38) disposed in each layer and plug connect erect frame pipes (40) disposed between two adjacent layers. Barriers (81, 82, 83, etc) are disposed within the framework's space units (70) to create obstacles whilst mesh plates are disposed on floors or walls of the space units to form channels in the training device (1). The training device (1) is reconfigurable to simulate different obstacles and modes of rescue train­ ing in narrow spaces. The training device (1) can be disassembled and reassembled into frameworks of vari­ ous shapes.
Patent SG-11201805276V-A (SG)
Title: METHOD FOR CLEANING SiC MONOCRYSTAL GROWTH FURNACE
Inventor: TANIMOTO YOSUKE
IPC: C23C14/00
Filed: 2016-12-26
Abstract: This method of cleaning a SiC monocrystal growth furnace uses a gas to clean a SiC monocrystal growth furnace provided with an in-furnace substrate composed of a 3C-SiC polycrystal having at least a surface in which an intensity ratio of a (111) plane with respect to other crystal planes is at least 85% but not more than 100% according to powder XRD analysis, the method including flowing a mixed gas of fluorine gas and at least one of an inert gas and air in a non-plasma state through the inside of the SiC monocrystal growth furnace, thereby selectively removing a SiC deposit deposited inside the SiC monocrystal growth furnace, wherein the mixed gas comprises at least I vol% but not more than 20 vol% of fluorine gas, and at least 80 vol% but not more than 99 vol% of an inert gas, and a temperature inside the SiC monocrystal growth furnace is at least 200°C but not more than 500°C.
Patent SG-11201809336Q-A (SG)
Title: Anti-pd-l1 antibodies
Inventor: KEYT BRUCE
IPC: C07K16/28
Filed: 2017-05-09
Abstract: International Patent Classification: CO7K 16/28 (2006.01) A61K 39/395 (2006.01) (21) International Application Number: PCT/US2017/031791 (22) International Filing Date: 09 May 2017 (09.05.2017) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 62/333,643 09 May 2016 (09.05.2016) US (71) Applicant: IGM BIOSCIENCES, INC. [US/US]; 325 East Middlefield Road, Mountain View, California 94043 (US). (72) Inventors: KEYT, Bruce; 325 East Middlefield Road, Mountain View, California 94043 (US). PRESTA, Leonard George; 325 East Middlefield Road, Mountain View, California 94043 (US). BALIGA, Ramesh; 325 East Middlefield Road, Mountain View, California 94043 (US). (74) Agent: PELLETIER, Benjamin C. et al.; Arnold & Porter Kaye Scholer LLP, Three Embarcadero Center, 10th Floor, San Francisco, California 94111 (US). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). (54) Title: ANTI-PD-L1 ANTIBODIES FIG. 1 Mouse anti- human PD-L1 Human PD-L1: human IgG Fc fusion protein Goat Anti-Mouse IgG Fc- HRP Plate coated with Goat anti-Human IgG Fc antibody (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 16 November 2017 (16.11.2017) WIPO I PCT omit VIII Hot 0 omiolu Elio° Imo oimIE (10) International Publication Number WO 2017/196867 Al N 00 O\ N 1-1 1-1 (57) : Aspects of the invention include isolated anti-PD-L1 antibodies, as well as compositions containing such antibodies, © and methods of using the same in the treatment of diseases or conditions that are mediated by PD-L1 signaling. O [Continued on next page] WO 2017/196867 Al MIDEDIMOMMIDIRMEMOMOHEIMEHMERVOIMIE Declarations under Rule 4.17: as to applicant's entitlement to apply for and be granted a patent (Rule 4.17(H)) as to the applicant's entitlement to claim the priority of the earlier application (Rule 4.17(iii)) Published: — with international search report (Art. 21(3))
Patent SG-11201810640R-A (SG)
Title: Cd33 specific chimeric antigen receptors
Inventor: SHAH RUTUL R
IPC: C07K14/705
Filed: 2017-06-07
Abstract: INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 14 December 2017 (14.12.2017) WIP0 I PCT Iiiimmomitia Hot o olo mil n n ono ow (10) International Publication Number WO 2017/214333 Al (51) International Patent Classification: C07K 16/28 (2006.01) CO7K 14/705 (2006.01) C07K 14/725 (2006.01) A61P 35/00 (2006.01) (21) International Application Number: PCT/US2017/036440 (22) International Filing Date: 07 June 2017 (07.06.2017) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 62/347,503 08 June 2016 (08.06.2016) US (71) Applicant: INTREXON CORPORATION [US/US]; 1750 Kraft Drive, Suite 1400, Blacksburg, Virginia 24060 (US). (72) Inventors: SHAH, Rutul R.; 14302 Harvest Moon Road, Boyds, Maryland 20841 (US). CHAN, Tim; 2508 Shel- ley Circle, Unit 2D, Frederick, Maryland 21702 (US). EM- TAGE, Peter; 3573 Terrace Way, Apt. 47, Lafayette, Cal- ifornia 94549 (US). YARLAGADDA, Ramya; 327 West Side Dr., Apt. 302, Gaithersburg, Maryland 20878 (US). (74) Agent: GIRINATH, Prashant; WILSON SONSINI GOODRICH & ROSATI, 650 Page Mill Road, Palo Alto, California 94304 (US). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Published: — with international search report (Art. 21(3)) before the expiration of the time limit for amending the claims and to be republished in the event of receipt of amendments (Rule 48.2(h)) with sequence listing part of description (Rule 5.2(a)) 71' 11 N (54) Title: CD33 SPECIFIC CHIMERIC ANTIGEN RECEPTORS 0 (57) : Provided herein are chimeric antigen receptors (CARs) for cancer therapy, and more particularly, CARs containing a \" scFv from a CD33 monoclonal antibody. Provided are immune effector cells containing such CARs, and methods of treating proffer- 0 ative disorders such as acute myeloid leukemia (AML), and relapsed or refractory AML.
Patent SG-11201907159S-A (SG)
Title: Treatment of hidradenitis suppurativa
Inventor: GIAMARELLOS-BOURBOULIS EVANGELOS
IPC: C07K16/24
Filed: 2018-02-16
Abstract: INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 23 August 2018 (23.08.2018) WIP0 I PCT °Ens °nolo HE looliolomu Imo ow (10) International Publication Number WO 2018/150265 Al (51) International Patent Classification: A61K 39/395 (2006.01) C07K 16/24 (2006.01) A61P 17/00 (2006.01) (21) International Application Number: PCT/IB2018/000209 (22) International Filing Date: 16 February 2018 (16.02.2018) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 62/459,841 16 February 2017 (16.02.2017) US (71) Applicant: XBIOTECH, INC. [CA/CA]; 1055 West Hast- ings Street, Suite 300, Vancouver, BC V6E 2E9 (CA). (72) Inventor; and (71) Applicant (for US only): KIM, Stanley, A. [US/US]; 5425 Park Central Court, Suite 111, Naples, FL 34109 (US). (72) Inventor: GIAMARELLOS-BOURBOULIS, Evange- los, J.; 21 Androutsou Street, 15351 Athens (GR). (74) Agent: KIM, Stanley, A.; XBiotech Inc., 5425 Park Central Court, Suite 111, Naples, FL 34109 (US). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Published: — with international search report (Art. 21(3)) — before the expiration of the time limit for amending the claims and to be republished in the event of receipt of amendments (Rule 48.2(h)) W O 20 18/ 15 0 265 Al (54) Title: TREATMENT OF HIDRADENITIS SUPPURATIVA (57) : Hidradenitis suppurativa can be treated by administering a pharmaceutical composition that includes a pharmaceutically acceptable carrier and a therapeutically effective amount of an agent that selectively binds interleukin-1a (IL-1a). Disclosed is the use of an antibody targeting and neutralizing interleukin 1 alpha (IL-1a), for the treatment of hidradenitis suppurativa (HS) in a human subject having lesions caused by the disease. More specifically, the use of the monoclonal antibody MABp1 is shown to be effective in reducing the number and/or size of inflammatory lesions in hidradenitis suppurativa.
Patent SG-11201909839X-A (SG)
Title: Liquid detergent composition for hard surface
Inventor: SAITO SHINYA
IPC: C11D1/68
Filed: 2018-10-16
Abstract: - Provided is a liquid detergent composition for hard surfaces which contains (a1) an amine oxide - type surfactant having at least one alkyl group or alkenyl group with 13 or more and 18 or less carbons [hereinafter, referred to as component (a1)]; and (b1) a sorbitan fat ty acid ester in which the fatty acid residue has 10 or more and 18 or less carbons [hereinafter, referred to as component (b1)]; and water, wherein the mass ratio of the content of component (a1) to the content of component (b1), (a1)/(b1), is 0.4 or more . Also provided is a liquid detergent composition for hard surfaces which contains a surfactant in an amount of 0.1% by mass or more and 20% by mass or less; and water, wherein the liquid detergent composition contains, as the surfactant, (a2) an amine ox ide - type surfactant having at least one alkyl group or alkenyl group with 7 or more and 12 or less carbons [hereinafter, referred to as component (a2)] and (b2) a glycerin fatty acid ester in which the fatty acid residue has 10 or more and 18 or less carbo ns [hereinafter, referred to as component (b2)], and wherein in the surfactant, the total content of the content of component (a2) and the content of component (b2) is 40% by mass or more.